Literature DB >> 15298554

Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.

A Di Stefano1, G Caramori, F L M Ricciardolo, A Capelli, I M Adcock, C F Donner.   

Abstract

In the last decade, the analysis of bronchial biopsies and lung parenchyma obtained from chronic obstructive pulmonary disease (COPD) patients compared with those from smokers with normal lung function and non-smokers has provided new insights on the role of the different inflammatory and structural cells, their signalling pathways and mediators, contributing to a better knowledge of the pathogenesis of COPD. This review summarizes and discusses the lung pathology of COPD patients with emphasis on inflammatory cell phenotypes that predominate in different clinical conditions. In bronchial biopsies, a cascade of events takes place during progression from mild-to-severe disease. T lymphocytes, particularly CD8+ cells and macrophages are the prevalent inflammatory cells in the lung of healthy smokers and patients with mild COPD, while total and activated neutrophils predominate in severe COPD. The number of CD4+, CD8+ cells and macrophages expressing nuclear factor-kappa B (NF-kappaB), STAT-4 and IFN-gamma proteins as well as endothelial adhesion molecule-1 in endothelium is increased in mild/moderate disease. In contrast, activated neutrophils (MPO+ cells) and increased nitrotyrosine immunoreactivity develops in severe COPD. In bronchial biopsies obtained during COPD exacerbations, some studies have shown an increased T cell and granulocyte infiltration. Regular treatment with high doses of inhaled glucocorticoids does not significantly change the number of inflammatory cells in bronchial biopsies from patients with moderate COPD. The profile in lung parenchyma is similar to bronchial biopsies. 'Healthy' smokers and mild/moderate diseased patients show increased T lymphocyte infiltration in the peripheral airways. Pulmonary emphysema is associated with a general increase of inflammatory cells in the alveolar septa. The molecular mechanisms driving the lymphocyte and neutrophilic prevalence in mild and severe disease, respectively, needs to be extensively studied. Up-regulation of pro-inflammatory transcription factors NF-kappaB and STAT-4 in mild, activated epithelial and endothelial cells in the more severe disease may contribute to this differential prevalence of infiltrating cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298554     DOI: 10.1111/j.1365-2222.2004.02030.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  57 in total

1.  Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis.

Authors:  Francesco Cappello; Gaetano Caramori; Claudia Campanella; Chiara Vicari; Isabella Gnemmi; Andrea Zanini; Antonio Spanevello; Armando Capelli; Giampiero La Rocca; Rita Anzalone; Fabio Bucchieri; Silvestro Ennio D'Anna; Fabio L M Ricciardolo; Paola Brun; Bruno Balbi; Mauro Carone; Giovanni Zummo; Everly Conway de Macario; Alberto J L Macario; Antonino Di Stefano
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

2.  Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease.

Authors:  Vasiliy V Polosukhin; Justin M Cates; William E Lawson; Rinat Zaynagetdinov; Aaron P Milstone; Pierre P Massion; Sebahat Ocak; Lorraine B Ware; Jae Woo Lee; Russell P Bowler; Alexey V Kononov; Scott H Randell; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

Review 3.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

4.  Ageing, smoking and oxidative stress.

Authors:  J F Donohue
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

5.  Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults.

Authors:  Rui Jiang; David C Paik; John L Hankinson; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

6.  High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function.

Authors:  Thomas H Thatcher; Randi P Benson; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-06-20       Impact factor: 5.464

7.  Correlation of Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema in C3H and C57Bl/6 Mice.

Authors:  Elias G Awji; Jean Clare Seagrave; Yohannes Tesfaigzi
Journal:  Toxicol Sci       Date:  2015-06-01       Impact factor: 4.849

8.  T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.

Authors:  A Di Stefano; G Caramori; I Gnemmi; M Contoli; C Vicari; A Capelli; F Magno; S E D'Anna; A Zanini; P Brun; P Casolari; K F Chung; P J Barnes; A Papi; I Adcock; B Balbi
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate.

Authors:  Yuanfu Xu; Hongmei Li; Besnik Bajrami; Hyunjeong Kwak; Shannan Cao; Peng Liu; Jiaxi Zhou; Yuan Zhou; Haiyan Zhu; Keqiang Ye; Hongbo R Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

Review 10.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.